SCM

Silverarc Capital Management Portfolio holdings

AUM $691M
1-Year Est. Return 223.03%
This Quarter Est. Return
1 Year Est. Return
+223.03%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$691M
AUM Growth
+$202M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
91
New
Increased
Reduced
Closed

Top Buys

1
+$45.8M
2
+$22.8M
3
+$18.9M
4
GUTS icon
Fractyl Health
GUTS
+$16.5M
5
QURE icon
uniQure
QURE
+$14.7M

Top Sells

1
+$39M
2
+$33.9M
3
+$20.5M
4
ETNB
89bio
ETNB
+$20M
5
SLNO icon
Soleno Therapeutics
SLNO
+$17.1M

Sector Composition

1 Healthcare 100%
2 Communication Services 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ETNB
76
DELISTED
89bio
ETNB
– –
-2,037,087
GPCR icon
77
Structure Therapeutics
GPCR
$2.17B
– –
-175,636
HIMS icon
78
Hims & Hers Health
HIMS
$9.05B
– –
0
MRUS icon
79
Merus
MRUS
$7.29B
– –
-741,972
NBIX icon
80
Neurocrine Biosciences
NBIX
$15.2B
– –
-162,969
PFE icon
81
Pfizer
PFE
$146B
– –
-344,338
RARE icon
82
Ultragenyx Pharmaceutical
RARE
$3.35B
– –
0
SGMT icon
83
Sagimet Biosciences
SGMT
$235M
– –
-37,539
SLNO icon
84
Soleno Therapeutics
SLNO
$2.71B
– –
-204,591
TRML
85
DELISTED
Tourmaline Bio
TRML
– –
-109,257
UTHR icon
86
United Therapeutics
UTHR
$20.9B
– –
0
VRNA
87
DELISTED
Verona Pharma
VRNA
– –
-358,297
XNTK icon
88
State Street SPDR NYSE Technology ETF
XNTK
$1.46B
– –
0
ATYR
89
aTyr Pharma
ATYR
$76.5M
– –
0
ORKA
90
Oruka Therapeutics
ORKA
$1.46B
– –
-165,389
MTSR
91
DELISTED
Metsera Inc
MTSR
– –
-207,581
1 2 3
4